...
首页> 外文期刊>Japanese journal of clinical oncology. >Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy.
【24h】

Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy.

机译:反复术后过继免疫治疗后转移性眼睑鳞状细胞癌和结肠腺癌患者的六年无病生存率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 74-year-old male was affected concurrently with squamous cell carcinoma of the left eyelid and adenocarcinoma of the colon, both with lymph node metastasis. He underwent exenteration of the left orbit with left modified radical neck dissection and subsequently resection of the transverse colon with regional lymph node dissection. The patient has been treated by an adoptive immunotherapy as a sole postoperative modality without receiving any chemotherapeutic agents causing immunosuppression. For the adoptive immunotherapy, autologous peripheral blood lymphocytes were activated with an immobilized anti-CD3 antibody and IL-2 for 14 days (the CD3-AT cells). The infusion with 1.38 x 10(10) CD3-AT cells has been repeated 150 times in total at the time of writing. Neither recurrence nor additional metastasis has been detected for 6 years after surgery.
机译:一名74岁的男性同时患有左眼睑鳞状细胞癌和结肠腺癌,均伴有淋巴结转移。他进行了左改良根治性颈淋巴结清扫术,并切除了左结肠,并进行了局部淋巴结清扫术。该患者已通过过继免疫疗法作为唯一的术后治疗方式,未接受任何引起免疫抑制的化学治疗剂。对于过继免疫疗法,用固定的抗CD3抗体和IL-2(CD3-AT细胞)激活自体外周血淋巴细胞14天。在撰写本文时,共注入了1.38 x 10(10)个CD3-AT细胞150次。手术后6年未发现复发或转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号